Vistagen Therap
VTGN----
Forecast & Rating4 analysts currently cover Vistagen Therap, of which 0 give a positive rating. The average price target is $1.00, about 255.9% upside from the current price of $0.28. Coverage is limited, so the data is for reference only. Data as of Sep 23, 2026; this does not constitute investment advice.
Sep 23, 2026Price forecast
$1.00255.87%
Forecast & RatingHold
4analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 28, 2026
Forecast met0.4%
Stock price$0.28
Avg. target$1.0
High target$1
Low target$1
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.